Literature DB >> 18306104

Immune activation by a sterile aqueous extract of Cordyceps sinensis: mechanism of action.

J L Jordan1, A M Sullivan, T D G Lee.   

Abstract

Cordyceps sinensis is a fungus that has been used for over 2,000 years in China as a treatment for a variety of conditions including infectious diseases. The available evidence suggests a hypothesis that any efficacy of C. sinensis as an anti-infective therapeutic would be related to a role as an activator of innate immune responses. The objectives of this study were first to investigate the ability of C. sinensis to activate pro-inflammatory responses in macrophages in vitro and induce protective responses against intracellular pathogens in vivo, and second to characterize a method of action. We found that C. sinensis activates murine macrophages to produce a variety of pro-inflammatory cytokines. IFN-gamma synergizes with C. sinensis to amplify this response. Bacterial endotoxin contamination was ruled out as a potential artefact. The evidence presented in this study supports a hypothesis that C. sinensis activates macrophages by engaging Toll-like receptors and inducing mitogen-activated protein kinase (MAPK) pathways characteristic of inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306104     DOI: 10.1080/08923970701812332

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  9 in total

1.  Cordyceps sinensis attenuates renal fibrosis and suppresses BAG3 induction in obstructed rat kidney.

Authors:  Feng Du; Si Li; Tian Wang; Hai-Yan Zhang; Zhi-Hong Zong; Zhen-Xian Du; De-Tian Li; Hua-Qin Wang; Bo Liu; Jia-Ning Miao; Xiao-Hui Bian
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

2.  A pre-trial evaluation of blinding for a Chinese herbal medicine trial.

Authors:  Shohreh Razavy; John Lee; Christopher Zaslawski
Journal:  Contemp Clin Trials Commun       Date:  2020-08-05

3.  Immunological alterations in lupus-prone autoimmune (NZB/NZW) F1 mice by mycelia Chinese medicinal fungus Cordyceps sinensis-induced redistributions of peripheral mononuclear T lymphocytes.

Authors:  Jiun-Liang Chen; Yen-Chen Chen; Sien-Hung Yang; Yun-Fei Ko; Shao-Yuan Chen
Journal:  Clin Exp Med       Date:  2009-04-07       Impact factor: 3.984

4.  Cordyceps sinensis protects against renal ischemia/reperfusion injury in rats.

Authors:  Hua-Pin Wang; Ching-Wen Liu; Hsueh-Wen Chang; Jen-Wei Tsai; Ya-Zhu Sung; Li-Ching Chang
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

Review 5.  A Systematic Review of the Mysterious Caterpillar Fungus Ophiocordyceps sinensis in Dong-ChongXiaCao ( Dōng Chóng Xià Cǎo) and Related Bioactive Ingredients.

Authors:  Hui-Chen Lo; Chienyan Hsieh; Fang-Yi Lin; Tai-Hao Hsu
Journal:  J Tradit Complement Med       Date:  2013-01

6.  Optimization of protein extraction and two-dimensional gel electrophoresis profiles for the identification of Cordyceps sinensis and other similar species.

Authors:  Roy Chi Ho Chan; Steven Sai Wo Lam; Fiona Long Yan Fong; Dominic Tak Wah Chan; Fred Wang Fat Lee; Eric Tung Po Sze
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

7.  Effects of FR-91 on immune cells from healthy individuals and from patients with non-Hodgkin lymphoma.

Authors:  V R M Lombardi; E Martínez; R Chacón; I Etcheverría; R Cacabelos
Journal:  J Biomed Biotechnol       Date:  2009-07-06

Review 8.  Entomopathogenicity and Biological Attributes of Himalayan Treasured Fungus Ophiocordyceps sinensis (Yarsagumba).

Authors:  Bikash Baral
Journal:  J Fungi (Basel)       Date:  2017-02-05

Review 9.  Antioxidant Activity of Mushroom Extracts/Polysaccharides-Their Antiviral Properties and Plausible AntiCOVID-19 Properties.

Authors:  Sechul Chun; Judy Gopal; Manikandan Muthu
Journal:  Antioxidants (Basel)       Date:  2021-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.